News
Rockwell Automation introduces PharmaSuite 12.00 to accelerate secure, scalable deployments: Milwaukee, Wisconsin Thursday, ...
GSK to buy Boston Pharma’s efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of SLD: London, UK Thursday, May 15, 2025, ...
HHS, US FDA issue RFI on deregulatory plan to lower costs and empower providers: Silver Spring, Maryland Thursday, May 15, 2025, 09:00 Hrs [IST] The US Department of Health and Hu ...
Dr Sunil Chiplunkar: Nandita Vijayasimha, Bengaluru Thursday, May 15, 2025, 08:00 Hrs [IST] There are two aggrieved pa ...
Trump’s EO on MFN prescription drugs to strengthen adoption of generics & biosimilars: Nandita Vijayasimha, Bengaluru Thursday, May 15, 2025, 08:00 Hrs [IST] US President Donald ...
Pharmexcil initiates high-level discussions with key ASEAN nations to strengthen pharma trade: Shardul Nautiyal, Mumbai Thursday, May 15, 2025, 08:00 Hrs [IST] In a strategic move ...
Peethaambaran Kunnathoor, Chennai Thursday, May 15, 2025, 08:00 Hrs [IST] ...
India invited to supply medicines to Chile’s National Health System: Shardul Nautiyal, Mumbai Thursday, May 15, 2025, 08:00 Hrs [IST] The Pharmaceuticals Export Promotion Counci ...
DTAB backs inclusion of name of authorised person of batch release on the license: Gireesh Babu, New Delhi Thursday, May 15, 2025, 08:00 Hrs [IST] The Drugs Technical Advisory Boa ...
Under this background, the appeal of the mothers and caregivers of children with rare diseases to the Supreme Court should be taken with the seriousness it deserves. Recently, relatives of rare ...
Hoth Therapeutics announces positive preclinical results for HT-KIT, a precision antisense therapy targeting rare and aggressive KIT-driven cancers: New York Wednesday, May 14, 20 ...
Hyderabad emerges as one of the top global centres of life sciences manufacturing: CBRE report: Our Bureau, Bengaluru Wednesday, May 14, 2025, 14:15 Hrs [IST] CBRE, world’s lead ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results